Explore more publications!

Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on November 3, 2025

Will Bitcoin Drop Below $100K? Volatility Is Unpredictable — AG META RWA Shows You How to Hedge Risks with Real Assets
Low Carbon Construction Materials Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Stacker Crane Market: Future Demand and Top Key Players Analysis | 2029
Membrane Separation Systems Market to Reach $47.69 Billion by 2029 with 9.6% CAGR
Micro Fulfillment Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029
Mobile Toilet Rental Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Molecular Spectroscopy Market Trends 2025-2029: Regional Outlook and Sizing Analysis
Multi-Vendor Support Services Market: Future Demand and Top Key Players Analysis | 2029
Builders Joinery And Carpentry Of Wood Market Size Worth $93.54 Billion by 2029 - Exclusive Report by TBRC
Building Management System Market Anticipated to Grow at 22.7% CAGR Through 2029: Industry Report
Concrete Delivery Hose Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029
Construction And Heavy Equipment Telematics Industry Report: Competitive Landscape and Future Prospects
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
Interior Design Services Market to Reach USD $119.8 Billion by 2029 at 8.3% CAGR
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
CryptoMondays: Where Decentralized Minds Meet to Build the Future
NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions